Helius Medical Technologies Inc. has announced an amendment to its 2022 Equity Incentive Plan, as approved by the Board of Directors and stockholders. Effective June 16, 2025, the plan's amendment increases the number of shares of common stock available for issuance by 20%, amounting to 7.1 million shares. This change follows the company's recent public offering closure and aims to adjust the incentive framework for the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Helius Medical Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008779), on June 20, 2025, and is solely responsible for the information contained therein.